Human Papillomavirus Vaccination Coverage among Girls before 13 Years: A Birth Year Cohort Analysis of the National Immunization Survey-Teen, 2008-2013

Clinical Pediatrics

Volumn 55, Issue 10, 2016, Pages 904-914

  Jeyarajah, Jenny ^a,b   Elam Evans, Laurie D ^b   Stokley, Shannon ^b   Smith, Philip J ^b   Singleton, James A ^b  

^a Carter Consulting Inc   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

achievable coverage; adolescent vaccination; birth year cohort; human papillomavirus; missed opportunity; trends in vaccination coverage; vaccination coverage

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; BIRTH; CLINICAL EVALUATION; COHORT ANALYSIS; FEMALE; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; OUTCOME ASSESSMENT; REVIEW; STATISTICAL ANALYSIS; UNITED STATES; VACCINATION; ATTITUDE TO HEALTH; CHILD; HEALTH CARE SURVEY; PAPILLOMAVIRUS INFECTIONS; STATISTICS AND NUMERICAL DATA;

CHILD; COHORT STUDIES; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UNITED STATES; VACCINATION;

EID: 84984699046     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/0009922815616245     Document Type: Review

References (29)

1. Markowitz LE, Dunne E, Saraiya M, Lawson H, Chesson H, Unger E,. Quadrivalent human papillomavirus vaccine vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56 (RR-2): 1-24.
2. Schiffman M, Castle PE,. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med. 2003; 127: 930-934.
3. Trottier H, Burchell AN,. Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics. 2009; 12: 291-307.
4. Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010; 59: 626-629.
5. Dunne EF, Markowitz LE, Chesson H, et al. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011; 60: 1705-1708.
6. Petrosky E, Bocchini JA Jr, Hariri S, et al.Centers for Disease Control and Prevention (CDC). Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015; 64: 300-304.
7. Saslow D, Castle PE, Cox JT, et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin. 2007; 57: 7-28.
8. Elam-Evans LD, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years-United States, 2013. MMWR Morb Mortal Wkly Rep. 2014; 63: 625-633.
9. Centers for Disease Control and Prevention (CDC). Vaccination coverage among adolescents aged 13-17 years: United States, 2007. MMWR Morb Mortal Wkly Rep. 2008; 57: 1100-1103.
10. Centers for Disease Control and Prevention. Datasets and related documentation for the National Immunization Survey-Teen, 2008-2014. http://www.cdc.gov/nchs/nis/data-files-teen.htm. Accessed January 7, 2015.
11. Stokley S, Jeyarajah J, Yankey D, et al. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014-United States. MMWR Morb Mortal Wkly Rep. 2014; 63: 620-624.
12. Zhao Z, Murphy TV, Jacques-Carroll L,. Progress in newborn hepatitis B vaccination by birth year cohorts-1998-2007, USA. Vaccine. 2011; 30: 14-20.
13. Laubereau B, Hermann M, Schmitt H, Weil J, Von Kries R,. Detection of delayed vaccinations: a new approach to visualize vaccine uptake. Epidemiol Infect. 2002; 128: 185-192.
14. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S,. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014; 168: 76-82.
15. Rand CM, Shone LP, Albertin C, Auinger P, Klein JD, Szilagyi PG,. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med. 2007; 161: 252-259.
16. Bednarczyk RA, Curran EA, Orenstein WA, Omer SB,. Health disparities in human papillomavirus vaccine coverage: trends analysis from the National Immunization Survey-Teen, 2008-2011. Clin Infect Dis. 2014; 58: 238-241.
17. Dorell C, Yankey D, Jeyarajah J, et al. Delay and refusal of human papillomavirus vaccine for girls, National Immunization Survey-Teen, 2010. Clin Pediatr. 2014; 53: 261-269.
18. Smith PJ, Chu SY, Barker LE,. Children who have received no vaccines: who are they and where do they live? Pediatrics. 2004; 114: 187-195.
19. Dorell CG, Yankey D, Santibanez TA, Markowitz LE,. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics. 2011; 128: 830-839.
20. Broder KR, Cohn AC, Schwartz B, et al. Adolescent immunizations and other clinical preventive services: a needle and a hook? Pediatrics. 2008; 121 (suppl 1): S25-S34.
21. Vadaparampil ST, Kahn JA, Salmon D, et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine. 2011; 29: 8634-8641.
22. Perkins RB, Clark JA, Apte G, et al. Missed opportunities for HPV vaccination in adolescent girls: a qualitative study. Pediatrics. 2014; 134: e666-e674.
23. Stokley S, Cohn A, Jain N, McCauley MM,. Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years: evaluation of the 2009 National Immunization Survey-Teen. Arch Pediatr Adolesc Med. 2011; 165: 813-818.
24. Daley MF, Crane LA, Markowitz LE, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics. 2010; 126: 425-433.
25. Centers for Disease Control and Prevention. Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013-United States. MMWR Morb Mortal Wkly Rep. 2013; 62: 591-595.
26. Lavelanet AF, Stampler KM, Dunton CJ,. Human papillomavirus vaccine uptake: what works and what can we do better? J Low GenitTract Dis. 2015; 19: e17-e22.
27. Stokley S,. Interventions to improve adolescent vaccination coverage. J Adolesc Health. 2015; 56 (5 suppl): S3-S4.
28. The Community Preventive Services Task Force. Increasing appropriate vaccination: health care system-based interventions implemented in combination. http://www.thecommunityguide.org/vaccines/universally/healthsysteminterventions.html. Accessed February 12, 2015.
29. Tissot AM, Zimet GD, Rosenthal SL, Bernstein DI, Wetzel C, Kahn JA,. Effective strategies for HPV vaccine delivery: the views of pediatricians. J Adolesc Health. 2007; 41: 119-125.